Hypopigmenting Disorders

Fig. 5.1
Facial postinflammatory hypopigmentation due to prior atopic dermatitis lesions
Table 5.1 demonstrates a broad overview of loss of pigmentation in children, reviewing patterns of information and techniques to enhance diagnostic accuracy [18].
Table 5.1
Diagnosis of hypopigmentation reviewed in this chapter
Type of hypopigmentation
History
Wood’s lamp
Morphology/distribution
Dermoscopy
Biopsy
Further testing
Pigmentary mosaicism
Birth to 2 years
Equivocal
Linear in the lines of Blaschko; Multiple Lesions can signal hypomelanosis of Ito or genetic abnormalities
NC
Only for fibroblast culture and genetic testing
Screening for other systems affected, e.g., neurological alterations can aid in long-term care
Incontinentia pigmenti, 4th stage
Few weeks of life to mid-childhood; follows prior vesiculation, verrucous changes, or hyperpigmentation in the same distribution
Negative
Linear lesions in the lines of Blaschko
NC
Would be beneficial only in the vesicular or verrucous stage
Genetic testing and evaluation of family member
Menkes kinky hair carrier
Congenital through adulthood
Negative
Linear along broad lines of Blaschko
NC
NC
Genetic testing and evaluation of family member
Nevus depigmentosus
Birth through age 2 years
Negative
Annular area of partial pigment loss
NC
Genetic alterations could be detectable through culture of cells in this area and normal areas of pigmentation
Mexameter can differentiate from vitiligo
Not necessary unless morphology is more consistent with ash leaf macules of tuberous sclerosis
Morphea
Childhood or adolescent acute onset; pruritus, burning, or pain can be associated; linear lesions (segmental form) can be noted and are associated with limb movement limitation and intracranial problems
Positive in some cases
Annular violaceous bound down plaques over the trunk or extremities
Vascular ectasia, atrophic epidermis might be noted
Biopsy would confirm morphea diagnosis
Not necessary unless linear lesions are noted over the head or neck
Lichen striatus
Onset in Spring, Summer, or fall abrupt and progressive distally to proximally along the extremities or on the face
Negative
Linear grouped small erythematous to flesh-colored papules resolving with hypopigmentation along the lines of Blaschko
Shows vascular ectasia and hyperkeratosis
Biopsy can demonstrate ball and claw lymphocytic clusters in the dermis
None needed
Postinflammatory pigmentary alteration
Any age, following the occurrence of cutaneous inflammation
Negative
Morphology consistent with previous insult
NC
Biopsy demonstrates presence of melanocytes
None needed
Waardenburg’s syndrome
Congenital onset
NC
Hypopigmentation of the anterior shins with islands of repigmentation; typical clinical appearance, e.g., heterochromic irides, dystopia canthorum
NC
Biopsy may demonstrate absence of melanocytes
Genetic testing/counseling; Hearing screen; Check for signs of Hirschsprung’s disease (rectal exam)
Piebaldism
Congenital onset
NC
White forelock
Irregular white patches on face, trunk, and extremities often symmetrically distributed
NC
Biopsy may demonstrate absence of melanocytes
Genetic testing, family history
Mycosis fungoides
School-aged to adolescents
Positive in hypopigmented variant
Trunk, buttocks, and proximal extremities symmetric hypopigmented plaques with fine hyperkeratosis
Fine hyperkeratosis; vascular ectasia mild
Atypical lymphocytes; T-cell gene rearrangements
Good long-term prognosis
Nutritional Deficiencies
– Kwashiorkor
– Fad diets/food avoidance
– Eating disorders
– Gastrointestinal disease (IBD, pancreatic insufficiency, gastric bypass surgery)
– Vitamin B12 deficiency
– Vitamin D deficiency
– Selenium deficiency
– Homocysteinuria
Any aged child
Negative
Generalized hypopigmentation; hyperkeratosis; central enhancement
NC
May depend on the deficiency; often with pallor and ballooning of upper epidermis
Associated with malnutrition and gastric bypass procedures in adolescents. Type of cutaneous alteration depends on specific nutritional deficiency
Vitiligo
Onset in Spring of progressive pigment loss
Positive for highlighting
Hypopigmentation with good demarcation anywhere on the body, especially periorificial and intertriginous or over the joints of the extremities
NC
Biopsy would confirm the absence of melanocytes and potentially demonstrate lymphocytic infiltration at the active border
Mexameter can differentiate from nevus depigmentosus
Thyroid tests and vitamin D levels are monitored standardly, but screening for other autoimmune illnesses can be performed on a case-by-case level
Oculocutaneous albinism
At birth
Negative
Generalized Hypopigmentation with or without pigmentary loss of the eye and/or hair
NC
Biopsy would confirm presence of melanocytes
Genetic testing and family history/screening may reveal the type associated with pigment loss
Tuberous sclerosis
At birth
Negative or equivocal
Hypopigmentation in format of thumbprints, confetti-like macules, and/or ash leaf macules; Later in childhood adenoma sebaceum, shagreen patch, and/or Koenen’s tumor
NC
Biopsy pattern is in the differential of normal; however less melanin would be noted with special stains if compared to normal skin
Annual skin examination. Genetic screen, MRI of the head, neurologic evaluation, cardiac evaluation, nephrology evaluation, and developmental evaluation may all be appropriate in these patients.
NC non-contributory
Tey recently described a basic paradigm to help diagnose hypopigmentation of childhood [6]. The classification developed is based on age at diagnosis, with division as “early” onset by 2 years of age vs. “late” onset age two or older. Further division by localized vs. generalized illness helps to discern diagnosis. The paradigm has one caveat: many congenital lesions have late expression, particularly in light-skinned children (e.g., nevus depigmentosus and pigmentary mosaicism). Furthermore there are rare situations where autoimmune or autoinflammatory diseases are congenital or extremely early in onset. Finally, most children of Black/African descent will develop hypopigmentation in response to seborrheic and/or atopic dermatitis (Fig. 5.1). Therefore we advocate a ten-step approach to evaluation of hypopigmentation in children summarized in Table 5.2.
Table 5.2
Ten-step approach to the diagnosis of hypopigmentation in childhood
Step 1: History
Age of onset
Presence of pigmentary loss in the hair or eyes
Review of past medical history including structural anomalies, intellectual impairments or learning disabilities, prior dermatitis, systemic illness (e.g., lupus erythematosus), drug exposures (e.g., hydroxychloroquine, antibiotics)
Personal/family history of seizures, autoimmunity, melanoma, atopy, and hypopigmentation
Step 2: Examination with and without Wood’s lamp
Examine the patient in good lighting without a spotlight or halogen light for the skin, mucosa, hair, and eyes
Review of the skin for other skin findings consistent with diagnoses such as angiofibromas of the face, Koenen’s tumors, or fibrous forehead plaque in tuberous sclerosis
Highlighting with Wood’s lamp is seen in vitiligo, but may be noted in other conditionsa
Step 3: Identification of lesion morphology
Confetti-like
Ovoid or annular
Over the joints or in the flexures
Placement along Langer’s lines
Placement along the lines of Blaschko
Step 4: Identification of lesional distribution
Site
Localized vs. generalized
Unilateral vs. bilateral
Flexural vs. extensor locations
Linear/Blaschkoid
Presence of Koebner phenomenon
Number of lesions
Step 5: Identification of lesion thickness
Check for sclerotic changes or atrophy
Identify subtle hyperkeratosis suggesting plaques
Step 6: Usage of dermoscopy where needed to identify
Dermal alterations
Dilated blood vessels
Subtle thinning
Underlying pattern of pigmentation or vasculature (e.g., amelanotic melanoma)
Hyperkeratosis
Poliosis in vitiligo
Step 7: How to identify suspicious lesions that require biopsy
Buttock, periorificial, atrophic or for suspicion of malignancy or poor response to therapeutic trials (see Step 9)
Step 8: Further ancillary testing
Infectious testing: KOH, fungal culture
Karyotyping/genetic evaluation/genetic testing
Biopsy for fibroblast testing
Other referrals: e.g., neurology, ophthalmology
Step 9: Using treatment trials to identify subtle diseases
Possible treatment trial of topical mid-potency corticosteroids or tacrolimus
Step 10: Using suspected diagnosis to determine which blood tests to draw
aSilverberg JI, Silverberg NB. False “highlighting” with Wood’s lamp. Pediatr Dermatol. 2012. doi:10.​1111/​j.​1525-1470.​2012.​01787.​x [Epub ahead of print]

Diagnoses

Review of every cause of hypopigmentation is not possible in this chapter. Focus on the most common causes of hypopigmentation is given with specific review by diagnosis (Table 5.1).
A310620_1_En_5_Fig2_HTML.jpg
Fig. 5.2
Nevus depigmentosus on the face. This linear lesion was noted at birth. (From the Silverberg NB. Atlas of Pediatric Cutaneous Biodiversity. Spriner 2012, with permission)

Nevus Depigmentosus

Epidemiology

  • 0.4 % of Asian children are born with nevus depigmentosus [3].
  • 34.2 % of cases are present at birth and most are present by age 3 years [1].
  • Nevus depigmentosus is common in Hispanic children [11].
  • 10.18 % of children seen for hypopigmentation in an Indian clinic were seen for nevus depigmentosus [2].
  • Multiple areas of pigmentary loss are uncommon and require careful evaluation for associated genetic syndromes.
Post-zygotic alterations in pigment genes occur and can generate localized ovoid areas of hypopigmentation termed nevus depigmentosus. Single areas of pigment loss, similar in shape to a café au lait spot, are not uncommon in children of color, especially Hispanic children; however, multiple areas of pigmentary alteration are uncommon and require genetic work-up for genetic and/or chromosomal abnormalities and conditions such as tuberous sclerosis (ash leaf macules, confetti, and thumbprint-like hypopigmentation) [1, 9, 10]. 34.2 % of lesions are seen at birth and most lesions are noted by 3 years of age [1].

Clinical Presentation

  • Nevus depigmentosus is a localized hypopigmentation usually on the trunk or limbs that does not enhance on Wood’s lamp examination.
  • Lesions appear anytime from birth to age 2 years and may not become prominent until pigmentary development obviates the lesions.
Nevus depigmentosum is a localized ovoid area of hypopigmentation that is non-enhancing with Wood’s lamp (Fig. 5.2). Lesional appearance may be noted at birth or as late as age 3 years due to delayed pigmentary development. Hypopigmentation of the overlying hairs, the adjacent iris, and the mucosa can accompany a nevus depigmentosus [11]. Lesions are most commonly noted on the trunk, followed by the extremities. Wood’s lamp examination can be used to identify early or subclinical lesions. The mexameter can be used to differentiate the nevus depigmentosus from vitiligo, by relative melanin index [12]. Similarly, in vivo confocal reflectance microscopy can be used to differentiate these lesions from vitiligo [13]. Differentiation from the ash leaf macules of tuberous sclerosis can be difficult and requires a high level of vigilance in screening for the stigmata of tuberous sclerosis. Biopsy shows normal number of melanocytes and reduced pigmentation of the epidermis with clumped melanosomes [5, 14].

Treatment

  • No treatment exists to remove these lesions other than surgery.
  • Excimer light sources can temporarily tan lesions to make them less obvious.
  • >Usage of grafts of pigmented skin or melanocytes can aid in lesional clearance.
No current therapy for permanent removal, other than surgery, exists. Suction blister grafts and melanocyte keratinocyte grafts have been described to help clear lesions [15, 16]. Excimer laser has been described to reduce the prominence of these lesions [17]. A treatment trial with excimer laser can produce alterations on mexameter that differentiate such lesions from vitiligo. Pigmentary differences may become less marked with time in some children and disappearance can occur [18].

Menkes Kinky Hair Carrier

Epidemiology

  • Menkes kinky hair disease is a rare X-linked recessive defect in copper transport gene ATP7A associated with generalized hypopigmentation and neurologic degeneration [19]

Clinical Presentation

  • Female carriers, due to random X inactivation, can present with localized or flag-like areas of hypopigmentation and variable neurologic defects [20].

Treatment

  • No treatment exists for the therapy of the carrier state of Menkes disease.
  • Prenatal diagnosis can be performed to prevent transmission of the gene when the mutation has been identified in the ATPA7 gene [21].

Lichen Striatus

Epidemiology

  • Lichen striatus is a common, self-limited condition of childhood
Lichen striatus is a common, self-limited condition of childhood seen in children of all ages and ethnicities and occurring year round. In a survey of 113 Indian children seen for hypopigmentation, 2 children had lichen striatus [1].

Clinical Presentation

  • Lichen striatus is typified by two phases of disease, a papular/eczematous phase [22] with a spreading, erythematous to flesh-colored plaque occurring along the lines of Blaschko
  • A second phase characterized by prolonged postinflammatory hypopigmentation in children of color is noted upon clearance of the first stage
  • Lesions are most common on the lower extremities
Lichen striatus can be seen in children of all ages after infancy and follows a classical clinical course beginning with raised papular lesions that are erythematous to flesh colored along the lines of Blaschko, starting usually distally and progressing proximally along the lower extremity. It is usual for only one segment to be involved, but multiple segment involvement can occur [2325]. Involvement of the nail with a non-scarring, self-limited dystrophy can be noted [26]. No seasonality is noted in larger studies. Upon resolution of the first phase, which usually takes 6 months but can rarely persist for 3–4 years, hypopigmentation will be noted in most children of Fitzpatrick types IV or higher (Fig. 5.4), with erythema as a sequela in some Asian children. Facial lichen striatus may resolve more rapidly according to one inner city study from the United States [27]. One case has been reported after allogeneic bone marrow transplant [28].

Treatment

  • Natural clearance is expected without scarring; therefore, therapy is not required.
  • Therapies can be used to reduce pruritus or erythema or for cosmesis.
While natural clearance is expected in most cases, in those individuals with symptoms or prominent lesions, topical pimecrolimus, tacrolimus [29], or retinoids with topical cortisteroids can be used to improve lesional appearance. Photodynamic therapy has been described as well [30, 31].

Pigmentary Mosaicism/Hypomelanosis of Ito

Epidemiology

  • Linear pigmentation along these embryological lines is termed pigmentary mosaicism
  • When associated with structural or developmental anomalies, pigmentary mosaicism is termed hypomelanosis of Ito.
The incidence of pigmentary mosaicism is unknown, but it is not rare, while hypomelanosis of Ito is uncommon, occurring in only 20–30 % of individuals with pigmentary mosaicism. There is no race or ethnicity more likely to be affected; however, due to lyonization, females may be more likely to manifest pigmentary mosaicism (Fig. 5.3).
A310620_1_En_5_Fig3_HTML.jpg
Fig. 5.3
Linear hypopigmentation after flattening of the papular phase of lichen striatus

Clinical Presentation

  • Hypopigmentation along the lines of Blaschko that is Wood’s lamp negative or equivocal
  • Multiple lesions, in association with structural and/or developmental anomalies, are termed hypomelanosis of Ito
Pigmentary mosaicism usually appears at birth in darkly pigmented children, such as Indian or African-American children, or sometime in the first 2 years of life in Hispanic or Asian children. Mosaicism can be accompanied by hypertrichosis or hypotrichosis (Fig. 5.4).
A310620_1_En_5_Fig4_HTML.jpg
Fig. 5.4
Linear Hypopigmentation in a patten consistent with pigmentary mosaicism

Treatment

No current therapies are available for this disorder; however, judicious clinical monitoring for structural anomalies is recommended
While pigmentary mosaicism cannot be reversed, clinical monitoring is required developmentally in growth, limb lengths, and/or physical or speech development. Cardiac development, brain structure, and ocular development should be monitored.

Incontinentia Pigmenti

Epidemiology

  • X-linked dominant disorder that is rare
Incontinentia pigmenti (IP) is an X-linked dominant disorder that only rarely affects living male children. It results from mutations in the nuclear factor-ΚB (NEMO/IKBKG) [32].

Clinical Presentation

  • Four stages of development: vesicular, verrucous, hyperpigmentation, and hypopigmentation
  • Dental, neurologic, and ocular anomalies can accompany the cutaneous features
IP is apparent at birth or within a few weeks of birth. There are four well-recognized clinical stages of IP. Stage I is apparent at birth or up to 2 weeks of age and consists of linearly arranged vesicles, bullae, erythematous papules, pustules, and erythematous macules. Stage II of IP occurs between week 2 and week 6 of life consisting of linearly arranged verrucous papules. Hyperpigmentation along the lines of Blaschko characterize Stage III beginning at 3–6 months of age. Stage IV consisting of whorled hypopigmentation +/− atrophy, usually, is apparent by the second to third decade of life [32, 33].
Other clinical findings of IP may include pegged/conical teeth, scarring alopecia, dystrophic nails, ophthalmic abnormalities, seizures, mental retardation, and paralysis [32, 33]. (Also see pages 46-47).

Treatment

  • No current therapy exists for IP
No current treatment exists for IP and treatment is not required clinically. Children who survive infancy have a good prognosis.
A310620_1_En_5_Fig5_HTML.jpg
Fig. 5.5
Progressive macular hypomelanosis

Nutritional Deficiencies Causing Hypopigmentation (Table 5.1)

Kwashiorkor

  • Protein-energy malnutrition (PEM) is the most common cause of nutritional deficiency worldwide. The two main forms are marasmus and kwashiorkor.
  • Kwashiokor is defined as total body weight of 60–80% that expected for age and height with either edema and/or hypoalbuminemia.
Kwashiorkor is due to insufficient protein intake, despite sufficient caloric intake, and is often seen in children with diets consisting entirely of rice or rice-based beverages. The children often develop failure to thrive, edema, and moon facies, as well as, marked muscle atrophy, hepatomegaly, and a distended abdomen with dilated intestinal loops. Frequent superimposed bacterial and fungal infections often complicate this condition. While PEM is rarely seen in developed countries, Lui et al. reported 12 cases of kwashiorkor diagnosed in the US in children without chronic medical illness. Six of the twelve cases were the result of poor nutritional education, fad diets, presumed food allergy and/or specific food avoidance.
Cutaneous manifestations include generalized hypopigmentation, dyschromia, pallor and xerosis. In mild cases, a superficial desquamation resembling flaking paint (“enamel paint spots”) can be seen, while in more severe cases, confluent areas of eroded skin can occur. The hair in these patients can become thin, dry and abnormally pigmented, with a reddish tinge or occasionally even grey/white. The hair can also develop bands of light and dark colors, referred to as a “flag sign” which represents alternating periods of malnutrition and improvement of nutritional status. Clinical diagnosis should be confirmed with more objective markers including: easily detached hair, edema, skin fissures, faulty wound healing and skin anergy, as well as, albumin < 2.8 g/dl, transferrin < 150 mg/dl or total iron binding capacity < 200mcg/dl. Leukopenia can also be seen due to decreased cellular immunity.
Fad diets, restrictive diets and eating disorders can also result in malnutrition and ultimately kwashiorkor. As in classic cases of kwashiorkor as described above, protein-energy malnutrition from diets can lead to similar cutaneous findings, such as xerosis and pigmentary changes of the skin and hair, and may even be the first appreciable signs of an eating disorder. A 2009 report described a 28 year old woman who presented for evaluation of scaly skin rash and lightening of hair color from brown to blond over the course of 4 years. After an extensive GI evaluation was performed, the patient was ultimately found to have combined vitamin and mineral deficiencies as well as kwashiorkor in the setting of anorexia nervosa and alcohol abuse.
Chronic malabsorptive states, such as those secondary to inflammatory bowel disease, celiac disease, pancreatic insufficiency and post GI surgery, can all lead to nutritional deficiencies. Protein-energy malnutrition has been reported in each of these settings resulting in kwashiorkor with associated findings of xerosis and hypopigmentation. Kwashiokor has been reported in the setting of infantile Crohn’s disease with reversal of symptoms noted 2 weeks after treatment with prednisolone, azathioprine and nutritional supplementation. A 2011 case report of a Type 4/5 dark skinned patient with Kwashiokor secondary to a Whipple procedure used to treat chronic pancreatitis with pseudotumor at the head of the pancreas, demonstrated marked hypopigmentation of the skin and hair as well as ichthyosiform, xerotic skin. The patient was treated with a combination of nutritional support (hypercaloric oral diet, hyperproteic and with medium-chain triglycerides), vitamin supplements, oligoelements and oral replacement of pancreatic enzymes and within 3 months his pigmentation had returned to essentially normal.

Treatment

Treatment must be undertaken with caution, with a focus on correcting electrolyte abnormalities and treating infection. Malnutrition must be corrected with both balanced nutrition and increased caloric intake. Emollients can be used on the skin and cutaneous lesions tend to improve with treatment of the malnutrition.

Vitamin/Mineral/Enzyme Deficiencies

Vitmain deficiencies have also been implicated in hypopigmentation. A case of hyperpigmented macules on the body, longitundal hyperpigmented streaking on the nails and gingiva hyperpigmentation along with diffuse whitening of the hair in a 55 year old female was seen in the setting of Vitamin B12 deficiency. These pigmentary alterations were reversed in 2-3 months, with correction of her Vitamin B12 deficiency. Additionally, Extensive confetti like vitiligo has been described in association with extremely deficient levels of vitamin D.
Selenium deficiency, though rare, can be seen in cases of total parenteral nutrition (TPN), chronic bowel disease and following gastric bypass surgery. It can also be seen in people who survive on diets derived entirely from selenium deficient soil.

Postinflammatory Pigmentary Alteration

Epidemiology

  • Postinflammatory pigmentary alteration is a leading chief complaint for patients of color.
  • While the incidence is unknown in children, virtually all children of color will experience postinflammatory pigmentary alteration.
Postinflammatory pigmentary alteration is a pigmentary alteration of the skin that is seen in children of color from early infancy through adolescence. Causes of dyspigmentation include primarily hypopigmentation early on, with the leading insult being seborrheic dermatitis and atopic dermatitis (Fig. 5.1). With increasing age, hyperpigmentation is a common postinflammatory change, seen after bug bites, acne, and eczema lesional clearance.
A310620_1_En_5_Fig6_HTML.jpg
Fig. 5.6
Segmental vitiligo of the forehead

Clinical Presentation

  • Discrete, well-demarcated areas of pigmentary alteration, either hypopigmentation or hyperpigmentation, are noted.
  • Pigmentary alterations should be self-limited, but cantake years to resolve in darkly pigmented individuals.

Treatment

  • Resolution without therapy is expected in most cases
  • Therapies include treatment of the underlying cause and sun protection
  • Bleaching, chemical peels, and fraxel laser can be used in older patients to speed resolution.

Waardenburg’s Syndrome

Epidemiology

  • Waardenburg’s Syndrome is inherited via autosomal dominant inheritance and is characterized by four subtypes.
Waardenburg’s Syndrome types I and III are due to mutations in the PAX3 transcription factor gene. The PAX transcription factor is a key component in neural crest differentiation, melanoblast activation, melanoblast migration, and structures involving the facial bone, facial cartilage, and inner ear. Waardenburg’s Syndrome type II is due to a mutated melanocyte transcription factor, MITF gene. Type IV is due to mutations in SOX10 transcription factor, endothelin-3 gene, and endothelin receptor which all affect neural crest development [32].

Clinical Presentation

The main skin finding in Waardenburg’s Syndrome is depigmented patches with overlying hyperpigmented patches, i.e., islands of repigmentation. Other clinical features may include a white forelock, synophrys, dental caries, broad nasal root, dystopia canthorum (not in type II), heterochromia iridum, congenital sensorineural hearing loss (most common in type II), and Hirschsprung’s disease (type IV) [32, 34, 35]. Cleft lip and palate may be seen in type I and musculoskeletal defects of the upper limb and pectoral muscles may be seen in type III [32].

Treatment

  • There is no cure for Waardenburg’s Syndrome.
  • Patients should be evaluated by specialists who can address the known potential characteristics of the syndrome.
  • Pregnant mothers who have a family history of Waardenberg’s syndrome should take folic acid supplementation due to reported familial cases of neural tube defects.
Waardenburg’s syndrome patients should be screened by specialists for the known features of the syndrome. Hearing screen, rectal examination and genetic testing/counseling are reasonable screening tests for Waardenburg’s syndrome patients. There have been reports of neural tube defects in Waardenberg’s syndrome patients. Folic acid supplementation, though recommended for all women of child bearing age, may be of particular importance in this at risk group [36].

Piebaldism

Epidemiology

Nov 2, 2016 | Posted by in PEDIATRICS | Comments Off on Hypopigmenting Disorders

Full access? Get Clinical Tree

Get Clinical Tree app for offline access